These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 27855197)
1. Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis. Liu S; Xin X; Hua T; Shi R; Chi S; Jin Z; Wang H PLoS One; 2016; 11(11):e0166658. PubMed ID: 27855197 [TBL] [Abstract][Full Text] [Related]
2. Does the addition of drugs targeting the vascular endothelial growth factor pathway to first-line chemotherapy increase complete response? A meta-analysis of randomized clinical trials. Li Y; Liang XY; Yue YQ; Sheng L; Liu JK; Wang ZY; Chen G Tumour Biol; 2016 May; 37(5):6297-306. PubMed ID: 26619847 [TBL] [Abstract][Full Text] [Related]
3. Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats. Yildiz C; Kacan T; Akkar OB; Karakus S; Kacan SB; Ozer H; Cetin A Reprod Sci; 2015 Nov; 22(11):1445-51. PubMed ID: 25963915 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic therapy: targeting vascular endothelial growth factor and its receptors. Tandle A; Libutti SK Clin Adv Hematol Oncol; 2003 Jan; 1(1):41-8. PubMed ID: 16227959 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer: a systematic review and meta-analysis. Iacovelli R; Sternberg CN; Porta C; Verzoni E; de Braud F; Escudier B; Procopio G Curr Drug Targets; 2015; 16(2):164-70. PubMed ID: 25410406 [TBL] [Abstract][Full Text] [Related]
6. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291 [TBL] [Abstract][Full Text] [Related]
7. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Novella-Maestre E; Carda C; Noguera I; Ruiz-Saurí A; García-Velasco JA; Simón C; Pellicer A Hum Reprod; 2009 May; 24(5):1025-35. PubMed ID: 19189995 [TBL] [Abstract][Full Text] [Related]
8. The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathway. Roodhart JM; Langenberg MH; Witteveen E; Voest EE Curr Clin Pharmacol; 2008 May; 3(2):132-43. PubMed ID: 18690886 [TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis. Mendoza-Torreblanca JG; Cárdenas-Rodríguez N; Carro-Rodríguez J; Contreras-García IJ; Garciadiego-Cázares D; Ortega-Cuellar D; Martínez-López V; Alfaro-Rodríguez A; Evia-Ramírez AN; Ignacio-Mejía I; Vargas-Hernández MA; Bandala C Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373348 [TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic treatment strategies for the therapy of endometriosis. Laschke MW; Menger MD Hum Reprod Update; 2012; 18(6):682-702. PubMed ID: 22718320 [TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway. Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors. Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256 [TBL] [Abstract][Full Text] [Related]
13. Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis. Qi WX; Sun YJ; Tang LN; Shen Z; Yao Y Crit Rev Oncol Hematol; 2014 Mar; 89(3):394-403. PubMed ID: 24182420 [TBL] [Abstract][Full Text] [Related]
14. Amount of mRNA and localization of vascular endothelial growth factor and its receptors in the ovarian follicle during estrous cycle of water buffalo (Bubalus bubalis). Babitha V; Panda RP; Yadav VP; Chouhan VS; Dangi SS; Khan FA; Singh G; Bag S; Taru Sharma G; Silvia WJ; Sarkar M Anim Reprod Sci; 2013 Mar; 137(3-4):163-76. PubMed ID: 23375984 [TBL] [Abstract][Full Text] [Related]
15. Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review). Song G; Li Y; Jiang G Oncol Rep; 2012 Dec; 28(6):1935-44. PubMed ID: 22993103 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897 [TBL] [Abstract][Full Text] [Related]
17. [Anti-angiogenesis targeting drugs: a review]. Jia K; Li J Ai Zheng; 2008 Apr; 27(4):442-6. PubMed ID: 18423135 [TBL] [Abstract][Full Text] [Related]
18. TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics. Wheler JJ; Janku F; Naing A; Li Y; Stephen B; Zinner R; Subbiah V; Fu S; Karp D; Falchook GS; Tsimberidou AM; Piha-Paul S; Anderson R; Ke D; Miller V; Yelensky R; Lee JJ; Hong D; Kurzrock R Mol Cancer Ther; 2016 Oct; 15(10):2475-2485. PubMed ID: 27466356 [TBL] [Abstract][Full Text] [Related]
19. Targeting VEGF/VEGFR in the treatment of psoriasis. Li W; Man XY; Chen JQ; Zhou J; Cai SQ; Zheng M Discov Med; 2014 Sep; 18(98):97-104. PubMed ID: 25227750 [TBL] [Abstract][Full Text] [Related]
20. Angiogenesis inhibitors: a rational strategy for radiosensitization in the treatment of non-small-cell lung cancer? Raben D; Helfrich B Clin Lung Cancer; 2004 Jul; 6(1):48-57. PubMed ID: 15310417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]